Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C
about
Liver Fibrosis Quantification by Magnetic Resonance Imaging.Naturalizing activity and safety of human monoclonal antibodies against of hepatitis C virus.Evaluation the efficacy and safety of simultaneous splenectomy in liver transplantation patients: A meta-analysis.Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimens.
P2860
Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Future of liver disease in the ...... r the treatment of hepatitis C
@ast
Future of liver disease in the ...... r the treatment of hepatitis C
@en
type
label
Future of liver disease in the ...... r the treatment of hepatitis C
@ast
Future of liver disease in the ...... r the treatment of hepatitis C
@en
prefLabel
Future of liver disease in the ...... r the treatment of hepatitis C
@ast
Future of liver disease in the ...... r the treatment of hepatitis C
@en
P2093
P2860
P356
P1476
Future of liver disease in the ...... r the treatment of hepatitis C
@en
P2093
Antonio Gasbarrini
Antonio Grieco
Cecilia Binda
Francesca Mangiola
Francesca Romana Ponziani
Gian Lodovico Rapaccini
Massimo Siciliano
Maurizio Pompili
P2860
P304
P356
10.4254/WJH.V9.I7.352
P577
2017-03-01T00:00:00Z